Increased IgA Expression in Lung Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease.


Journal

American journal of respiratory and critical care medicine
ISSN: 1535-4970
Titre abrégé: Am J Respir Crit Care Med
Pays: United States
ID NLM: 9421642

Informations de publication

Date de publication:
01 03 2019
Historique:
pubmed: 20 10 2018
medline: 7 1 2020
entrez: 20 10 2018
Statut: ppublish

Résumé

Accumulation of B cells and lymphoid follicles (LFs) has been described in chronic obstructive pulmonary disease (COPD) airways, but the functional status of lung B cells remains poorly known. To characterize LFs for expression of IgA, the main mucosal antibody. The presence of B cells and LFs, including intrafollicular IgA expression, were determined in the lung from patients with COPD (n = 37) versus control subjects (n = 34) by immunohistochemistry. We also evaluated follicular IgA responses in the lungs from mice infected with Pseudomonas aeruginosa (PAO1) (n = 10 per group) and in smoking mice. Whereas in smokers B-cell numbers slightly increased, robust increases in B-cell and LF numbers (mainly in distal airways) were only observed in severe COPD. Most follicular B cells were IgM This study shows that IgA production occurs in peribronchiolar LFs from severe COPD, where IL-21-producing T cells are present, and presumably represents a feature of exacerbated mucosal adaptive immune responses against microbial and/or self-antigens.

Identifiants

pubmed: 30339768
doi: 10.1164/rccm.201802-0352OC
doi:

Substances chimiques

Immunoglobulin A 0
Interleukin-6 0
Interleukins 0
interleukin-21 MKM3CA6LT1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

592-602

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Auteurs

Maha Zohra Ladjemi (MZ)

1 Pôle de Pneumologie, ORL & Dermatologie.
2 Institute for Walloon Excellence in Lifesciences and Biotechnology, Brussels, Belgium.

Clémence Martin (C)

3 Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
4 Service de Pneumologie, Hôpital Cochin, Paris, France.

Marylène Lecocq (M)

1 Pôle de Pneumologie, ORL & Dermatologie.
5 Service de Pneumologie, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

Bruno Detry (B)

1 Pôle de Pneumologie, ORL & Dermatologie.
2 Institute for Walloon Excellence in Lifesciences and Biotechnology, Brussels, Belgium.

Frank Aboubakar Nana (FA)

1 Pôle de Pneumologie, ORL & Dermatologie.

Charlotte Moulin (C)

1 Pôle de Pneumologie, ORL & Dermatologie.

Birgit Weynand (B)

6 Pathologische Ontleedkunde, UZ Leuven, Leuven, Belgium.

Chantal Fregimilicka (C)

7 Institut de Recherche Expérimentale & Clinique Imaging Platform, Institut de Recherche Expérimentale & Clinique, Université Catholique de Louvain, Brussels, Belgium.

Caroline Bouzin (C)

7 Institut de Recherche Expérimentale & Clinique Imaging Platform, Institut de Recherche Expérimentale & Clinique, Université Catholique de Louvain, Brussels, Belgium.

Pascal Thurion (P)

8 Service d'anatomopathologie, CHU de Mont-Godinne, Yvoir, Belgium.

François Carlier (F)

1 Pôle de Pneumologie, ORL & Dermatologie.

Jef Serré (J)

9 KU Leuven, Laboratory of Respiratory Diseases, Leuven, Belgium; and.

Ghislaine Gayan-Ramirez (G)

9 KU Leuven, Laboratory of Respiratory Diseases, Leuven, Belgium; and.

Monique Delos (M)

8 Service d'anatomopathologie, CHU de Mont-Godinne, Yvoir, Belgium.

Sebahat Ocak (S)

1 Pôle de Pneumologie, ORL & Dermatologie.
10 Service de Pneumologie, CHU Université Catholique de Louvain Namur (Site Godinne), Yvoir, Belgium.

Pierre Régis Burgel (PR)

3 Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
4 Service de Pneumologie, Hôpital Cochin, Paris, France.

Charles Pilette (C)

1 Pôle de Pneumologie, ORL & Dermatologie.
2 Institute for Walloon Excellence in Lifesciences and Biotechnology, Brussels, Belgium.
5 Service de Pneumologie, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH